Stereotactic radiotherapy for spinal hemangioblastoma - disease control and volume analysis in long-term follow up.
Jakub CvekLukas KnybelStefan ReguliRadim LipinaPavla HanzlikovaPetr ŠilhánKamila ResovaTomas BlazekMartin PalickaDavid FeltlPublished in: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology (2022)
SBRT for pial-based spinal hemangioblastomas was an effective, safe, viable alternative to neurosurgery in asymptomatic patients. Escalating doses above the conventional dose-volume limits of spinal cord tolerance showed no additional benefit.